HealthEquity, Inc. (NASDAQ:HQY) Stock Holdings Decreased by Chase Investment Counsel Corp

Chase Investment Counsel Corp lessened its position in HealthEquity, Inc. (NASDAQ:HQY) by 85.5% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,923 shares of the company’s stock after selling 35,063 shares during the quarter. Chase Investment Counsel Corp’s holdings in HealthEquity were worth $484,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HQY. Mackenzie Financial Corp lifted its stake in HealthEquity by 16.0% in the second quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after acquiring an additional 325,906 shares during the last quarter. Generate Investment Management Ltd acquired a new position in HealthEquity during the second quarter worth $24,184,000. Thrivent Financial for Lutherans increased its position in HealthEquity by 924.2% during the second quarter. Thrivent Financial for Lutherans now owns 220,220 shares of the company’s stock worth $18,983,000 after buying an additional 198,718 shares during the last quarter. Vanguard Group Inc. raised its holdings in HealthEquity by 1.7% during the first quarter. Vanguard Group Inc. now owns 8,768,632 shares of the company’s stock valued at $715,783,000 after buying an additional 149,133 shares in the last quarter. Finally, Overbrook Management Corp acquired a new stake in shares of HealthEquity in the second quarter worth about $12,284,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Stock Performance

NASDAQ HQY opened at $100.20 on Wednesday. HealthEquity, Inc. has a twelve month low of $62.10 and a twelve month high of $101.17. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The stock has a market cap of $8.75 billion, a P/E ratio of 83.50, a PEG ratio of 1.57 and a beta of 0.52. The company’s 50-day simple moving average is $84.00 and its 200 day simple moving average is $80.74.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping the consensus estimate of $0.50 by $0.16. The business had revenue of $299.93 million during the quarter, compared to the consensus estimate of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. As a group, research analysts forecast that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Frank Corvino sold 1,247 shares of the stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the sale, the director now owns 4,823 shares in the company, valued at $387,093.98. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, Director Frank Corvino sold 1,247 shares of the firm’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the sale, the director now directly owns 4,823 shares of the company’s stock, valued at $387,093.98. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the transaction, the director now directly owns 54,719 shares in the company, valued at approximately $4,540,582.62. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 10,536 shares of company stock worth $884,517. Corporate insiders own 2.20% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on HQY shares. Royal Bank of Canada restated an “outperform” rating and issued a $92.00 target price on shares of HealthEquity in a report on Wednesday, September 4th. JMP Securities restated a “market outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. Barrington Research reiterated an “outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research note on Friday, September 20th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Finally, Bank of America dropped their price objective on HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, September 4th. Twelve analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $103.83.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.